SEQUENCES FOR DETECTION AND IDENTIFICATION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) OF MREJ TYPE XVIII

(19)

(11)

EP 4 043 882 A8

(12)	CORRECTED EUROPEAN PATENT APPLICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 A1)

(48)	Corrigendum issued on:
	12.10.2022 Bulletin 2022/41

(43)	Date of publication:
	17.08.2022 Bulletin 2022/33

(21)	Application number: 21211005.0

(22)	Date of filing: 10.10.2006

(51)

International Patent Classification (IPC):

G01N 33/569^(2006.01)
C07H 21/04^(2006.01)

C12Q 1/68^(2018.01)

(52)	Cooperative Patent Classification (CPC):
	C12Q 1/689; C12Q 2600/156

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30)

Priority:

11.10.2005 US 24843805

(62)	Application number of the earlier application in accordance with Art. 76 EPC:
	10016031.6 / 2325643
	06825875.5 / 1934613

(71)	Applicant: Becton Dickinson Infusion Therapy Systems Inc.
	Franklin Lakes, NJ 07417-1880 (US)

(72)	Inventors:
	HULETSKY, Ann Sillery, Québec G1S 4J3 (CA) GIROUX, Richard Sillery, Québec G1S 4B4 (CA)

(74)	Representative: Vossius & Partner Patentanwälte Rechtsanwälte mbB
	Siebertstraße 3 81675 München 81675 München (DE)


	Remarks:
	This application was filed on 29.11.2021 as a divisional application to the application mentioned under INID code 62.


	Remarks:
	Claims filed after the date of filing of the application / after the date of receipt of the divisional application (Rule 68(4) EPC).

(54)	SEQUENCES FOR DETECTION AND IDENTIFICATION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) OF MREJ TYPE XVIII

(57) ABSTRACT OF THE DISCLOSURE
Described herein are novel SCCmec right extremity junction (MREJ) sequences for the detection and/or identification of methicillin-resistant Staphylococcus aureus (MRSA). Disclosed are methods and compositions based on DNA sequences for the specific detection of MREJ sequences designated types xi, xii, xiii, xiv, xv, xvi, xvii, xviii, xix, and xx for diagnostic purposes and/or epidemiological typing.